ant-diabetic

Lincoln Pharmaceuticals Ltd reports 22.8% rise in the Standalone Net Profit at Rs. 21.6 crore in Q3 FY23

Highlights:- Total Income in Q3 FY23 at Rs. 140.12 crore, up 14.4% from Rs. 122.5 crore in Q3 FY22 During the year,…

2 years ago

Lincoln Pharmaceuticals Ltd plans to launch Cephalosporin products soon; Acquires a plant in Mehsana, Gujarat

Acquisition funded from Internal accruals; Expects turnover of Rs. 150 crore in next 3 years Highlights:- Investment in Cephalosporin plant…

3 years ago